Mechanisms of Weight Regain following Weight Loss

Erik Scott Blomain, Dara Anne Dirhan, Michael Anthony Valentino, Gilbert Won Kim, Scott Arthur Waldman, Erik Scott Blomain, Dara Anne Dirhan, Michael Anthony Valentino, Gilbert Won Kim, Scott Arthur Waldman

Abstract

Obesity is a world-wide pandemic and its incidence is on the rise along with associated comorbidities. Currently, there are few effective therapies to combat obesity. The use of lifestyle modification therapy, namely, improvements in diet and exercise, is preferable over bariatric surgery or pharmacotherapy due to surgical risks and issues with drug efficacy and safety. Although they are initially successful in producing weight loss, such lifestyle intervention strategies are generally unsuccessful in achieving long-term weight maintenance, with the vast majority of obese patients regaining their lost weight during followup. Recently, various compensatory mechanisms have been elucidated by which the body may oppose new weight loss, and this compensation may result in weight regain back to the obese baseline. The present review summarizes the available evidence on these compensatory mechanisms, with a focus on weight loss-induced changes in energy expenditure, neuroendocrine pathways, nutrient metabolism, and gut physiology. These findings have added a major focus to the field of antiobesity research. In addition to investigating pathways that induce weight loss, the present work also focuses on pathways that may instead prevent weight regain. Such strategies will be necessary for improving long-term weight loss maintenance and outcomes for patients who struggle with obesity.

References

    1. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nature Reviews Endocrinology. 2012;9(1):13–27.
    1. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008;16(10):2323–2330.
    1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012;(82):1–8.
    1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635–643.
    1. Eisenmann JC, Katzmarzyk PT, Perusse L, Tremblay A, Després JP, Bouchard C. Aerobic fitness, body mass index, and CVD risk factors among adolescents: the Québec family study. International Journal of Obesity. 2005;29(9):1077–1083.
    1. Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Smith GD. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. International Journal of Obesity. 2005;29(10):1267–1274.
    1. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Affairs. 2002;21(2):245–253.
    1. Russell GV, Pierce CW, Nunley L. Financial implications of obesity. Orthopedic Clinics of North America. 2011;42(1):123–127.
    1. Swinburn BA, Sacks G, Sing KL, et al. Estimating the changes in energy flux that characterize the rise in obesity prevalence. The American Journal of Clinical Nutrition. 2009;89(6):1723–1728.
    1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. The Journal of the American Medical Association. 2010;303(3):235–241.
    1. Bish CL, Blanck HM, Serdula MK, Marcus M, Kohl HW, Khan LK. Diet and physical activity behaviors among Americans trying to lose weight: 2000 behavioral risk factor surveillance system. Obesity Research. 2005;13(3):596–607.
    1. Kruger J, Galuska DA, Serdula MK, Jones DA. Attempting to lose weight: specific practices among U.S. adults. American Journal of Preventive Medicine. 2004;26(5):402–406.
    1. Andreyeva T, Long MW, Henderson KE, Grode GM. Trying to lose weight: diet strategies among Americans with overweight or obesity in 1996 and 2003. Journal of the American Dietetic Association. 2010;110(4):535–542.
    1. Berkel LA, Poston WS, Reeves RS, Foreyt JP. Behavioral interventions for obesity. Journal of the American Dietetic Association. 2005;105(Supplement 1)(5):S35–S43.
    1. Lang A, Froelicher ES. Management of overweight and obesity in adults: behavioral intervention for long-term weight loss and maintenance. European Journal of Cardiovascular Nursing. 2006;5(2):102–114.
    1. Nicklas JM, Huskey KW, Davis RB, Wee CC. Successful weight loss among obese U.S. adults. American Journal of Preventive Medicine. 2012;42(5):481–485.
    1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obesity Research. 1998;6(Supplement 2):51S–209S.
    1. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinology and Metabolism Clinics of North America. 2008;37(4):943–964.
    1. Choban PS, Jackson B, Poplawski S, Bistolarides P. Bariatric surgery for morbid obesity: why, who, when, how, where, and then what? Cleveland Clinic Journal of Medicine. 2002;69(11):897–903.
    1. Sarwer DB, Green AVS, Vetter ML, Wadden TA. Behavior therapy for obesity: where are we now? Current Opinion in Endocrinology, Diabetes and Obesity. 2009;16(5):347–352.
    1. Kraschnewski JL, Boan J, Esposito J, et al. Long-term weight loss maintenance in the United States. International Journal of Obesity. 2010;34(11):1644–1654.
    1. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661–671.
    1. Weigle DS. Appetite and the regulation of body composition. The FASEB Journal. 1994;8(3):302–310.
    1. Cao DX, Wu GH, Zhang B, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clinical Nutrition. 2010;29(1):72–77.
    1. Plasqui G, Westerterp KR. Seasonal variation in total energy expenditure and physical activity in Dutch young adults. Obesity Research. 2004;12(4):688–694.
    1. Bray GA, Smith SR, DeJonge L, et al. Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST study. International Journal of Obesity. 2012;36(3):448–455.
    1. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. The New England Journal of Medicine. 1995;332(10):621–628.
    1. Ebbeling CB, Swain JF, Feldman HA, et al. Effects of dietary composition on energy expenditure during weight-loss maintenance. The Journal of the American Medical Association. 2012;307(24):2627–2634.
    1. Krieger JW, Sitren HS, Daniels MJ, Langkamp-Henken B. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression. The American Journal of Clinical Nutrition. 2006;83(2):260–274.
    1. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. Journal of Nutrition. 2006;136(supplement 1):319S–323S.
    1. Layman DK, Evans EM, Erickson D, et al. A moderate-protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults. Journal of Nutrition. 2009;139(3):514–521.
    1. Larsen TM, Dalskov SM, Van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. The New England Journal of Medicine. 2010;363(22):2102–2113.
    1. MacLean PS, Higgins JA, Johnson GC, Fleming-Elder BK, Peters JC, Hill JO. Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats. American Journal of Physiology. 2004;287(2):R288–R297.
    1. Caton SJ, Yinglong B, Burget L, Spangler LJ, Tschöp MH, Bidlingmaier M. Low-carbohydrate high-fat diets: regulation of energy balance and body weight regain in rats. Obesity. 2009;17(2):283–289.
    1. Sumithran P, Proietto J. The defence of body weight: a physiological basis for weight regain after weight loss. Clinical Science. 2013;124(4):231–241.
    1. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543–546.
    1. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250–252.
    1. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. The Journal of Clinical Investigation. 1995;95(6):2986–2988.
    1. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes. 1996;45(3):992–994.
    1. Mapfei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1(11):1155–1161.
    1. Niskanen LK, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MIJ. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. European Journal of Endocrinology. 1997;137(1):61–67.
    1. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes. 1996;45(3):984–987.
    1. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. The Lancet. 1996;348(9021):159–161.
    1. Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. The Journal of Clinical Investigation. 1997;99(3):385–390.
    1. Rezek M. The role of insulin in the glucostatic control of food intake. Canadian Journal of Physiology and Pharmacology. 1976;54(5):650–665.
    1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.
    1. Raben A, Tagliabue A, Christensen NJ, Madsen J, Holst JJ, Astrup A. Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. The American Journal of Clinical Nutrition. 1994;60(4):544–551.
    1. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. The Journal of Clinical Endocrinology and Metabolism. 2001;86(12, article 5992)
    1. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature. 2002;418(6898):650–654.
    1. Gutzwiller JP, Göke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999;44(1):81–86.
    1. Batterham RL, le Roux CW, Cohen MA, et al. Pancreatic polypeptide reduces appetite and food intake in humans. The Journal of Clinical Endocrinology and Metabolism. 2003;88(8):3989–3992.
    1. Valentino MA, Lin JE, Snook AE, et al. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. The Journal of Clinical Investigation. 2011;121(9):3578–3588.
    1. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance. Physiology and Behavior. 2008;94(2):169–177.
    1. Silva JE. Thyroid hormone control of thermogenesis and energy balance. Thyroid. 1995;5(6):481–492.
    1. Sumithran P, Prendergas LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. The New England Journal of Medicine. 2011;365(17):1597–1604.
    1. Varady KA, Tussing L, Bhutani S, Braunschweig CL. Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism. 2009;58(8):1096–1101.
    1. Adam TCM, Jochan J, Westerterp-Plantenga MS. Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects. Obesity Research. 2005;13(4):710–716.
    1. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels. International Journal of Obesity. 2010;34(8):1239–1242.
    1. Kong WM, Sheikh MH, Lumb PJ, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. American Journal of Medicine. 2002;112(5):348–354.
    1. Lechan RM, Fekete C. Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome. Journal of Endocrinological Investigation. 2004;27(supplement 6):105–119.
    1. Solanes G, Pedraza N, Calvo V, Vidal-Puig A, Lowell BB, Villarroya F. Thyroid hormones directly activate the expression of the human and mouse uncoupling protein-3 genes through a thyroid response element in the proximal promoter region. Biochemical Journal. 2005;386, part 3:505–513.
    1. Bianco AC, Maia AL, da Silva WS, Christoffolete MA. Adaptive activation of thyroid hormone and energy expenditure. Bioscience Reports. 2005;25(3-4):191–208.
    1. Al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. Journal of Clinical Endocrinology and Metabolism. 1997;82(4):1118–1125.
    1. Mitchell CS, Savage DB, Dufour S, et al. Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. The Journal of Clinical Investigation. 2010;120(4):1345–1354.
    1. Marine N, Hershman JM, Maxwell MH, Dornfeld LP, Schroth P. Dietary restriction on serum thyroid hormone levels. American Journal of the Medical Sciences. 1991;301(5):310–313.
    1. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM. Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. Journal of Clinical Endocrinology and Metabolism. 1990;70(6):1631–1636.
    1. Wadden TA, Mason G, Foster GD, Stunkard AJ, Prange AJ. Effects of a very low calorie diet on weight, thyroid hormones and mood. International Journal of Obesity. 1990;14(3):249–258.
    1. Kozłowska L, Rosołowska-Huszcz D. Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit. Endocrine. 2004;24(2):147–153.
    1. O’Brian JT, Bybee DE, Burman KD. Thyroid hormone homeostasis in states of relative caloric deprivation. Metabolism. 1980;29(8):721–727.
    1. Doucet E, Imbeault P, St-Pierre S, et al. Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. International Journal of Obesity. 2000;24(7):906–914.
    1. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes. 1997;46(4):717–719.
    1. Johnstone AM, Faber P, Andrew R, et al. Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. European Journal of Endocrinology. 2004;150(2):185–194.
    1. Tomiyama AJ, Mann T, Vinas D, Hunger JM, Dejager J, Taylor SE. Low calorie dieting increases cortisol. Psychosomatic Medicine. 2010;72(4):357–364.
    1. Galvao-Teles A, Graves L, Burke CW. Free cortisol in obesity; effect of fasting. Acta Endocrinologica. 1976;81(2):321–329.
    1. Ho JT, Keogh JB, Bornstein SR, et al. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function. Hormone and Metabolic Research. 2007;39(9):694–699.
    1. Jackson SJ, Leahy FE, McGowan AA, Bluck LJC, Coward WA, Jebb SA. Delayed gastric emptying in the obese: an assessment using the non-invasive 13C-octanoic acid breath test. Diabetes, Obesity and Metabolism. 2004;6(4):264–270.
    1. Wright RA, Krinsky S, Fleeman C. Gastric emptying and obesity. Gastroenterology. 1983;84(4):747–751.
    1. Zahorska-Markiewicz B, Jonderko K, Lelek A, Skrzypek D. Gastric emptying in obesity. Human Nutrition. 1986;40(4):309–313.
    1. Glasbrenner B, Pieramico O, Brecht-Krauss D, Baur M, Malfertheiner P. Gastric emptying of solids and liquids in obesity. Clinical Investigator. 1993;71(7):542–546.
    1. Cardoso A, vaz Coelho LG, Savassi-Rocha PR, et al. Gastric emptying of solids and semi-solids in morbidly obese and non-obese subjects: an assessment using the 13C-octanoic acid and 13C-acetic acid breath tests. Obesity Surgery. 2007;17(2):236–241.
    1. Duggan JP, Booth DA. Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science. 1986;231(4738):609–611.
    1. Horowitz M, Su YC, Rayner CK, Jones KL. Gastroparesis: prevalence, clinical significance and treatment. Canadian Journal of Gastroenterology. 2001;15(12):805–813.
    1. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001;121(3):526–535.
    1. Verdich C, Madsen JL, Toubro S, Buemann B, Holst JJ, Astrup A. Effect of obesity and major weight reduction on gastric emptying. International Journal of Obesity. 2000;24(7):899–905.
    1. Tosetti C, Corinaldesi R, Stanghellini V, et al. Gastric emptying of solids in morbid obesity. International Journal of Obesity and Related Metabolic Disorders. 1996;20(3):200–205.
    1. Mathus-Vliegen EMH, van Ierland-van Leeuwen ML, Bennink RJ. Influences of fat restriction and lipase inhibition on gastric emptying in obesity. International Journal of Obesity. 2006;30(8):1203–1210.
    1. Hutson WR, Wald A. Obesity and weight reduction do not influence gastric emptying and antral motility. American Journal of Gastroenterology. 1993;88(9):1405–1409.
    1. Oliván B, Teixeira J, Bose M, et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Annals of Surgery. 2009;249(6):948–953.
    1. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. 2008;93(7):2479–2485.
    1. Cameron JD, Goldfield GS, Cyr MJ, Doucet E. The effects of prolonged caloric restriction leading to weight-loss on food hedonics and reinforcement. Physiology and Behavior. 2008;94(3):474–480.
    1. Drewnowski A, Brunzell JD, Sande K. Sweet tooth reconsidered: taste responsiveness in human obesity. Physiology and Behavior. 1985;35(4):617–622.
    1. Rosenbaum M, Goldsmith R, Bloomfield D, et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. The Journal of Clinical Investigation. 2005;115(12):3579–3586.
    1. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. The Journal of Clinical Investigation. 2008;118(7):2583–2591.
    1. Kissileff HR, Thornton JC, Torres MI, et al. Leptin reverses declines in satiation in weight-reduced obese humans. The American Journal of Clinical Nutrition. 2012;95(2):309–317.
    1. Valentino MA, Lin JE, Waldman SA. Central and peripheral molecular targets for antiobesity pharmacotherapy. Clinical Pharmacology and Therapeutics. 2010;87(6):652–662.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다